Neovasc (TSX:NVCN) Price-to-Operating-Cash-Flow : (As of May. 06, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Neovasc Price-to-Operating-Cash-Flow?

As of today (2024-05-06), Neovasc's share price is C$40.15. Neovasc's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2022 was C$-11.92. Hence, Neovasc's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Neovasc's Price-to-Operating-Cash-Flow or its related term are showing as below:

TSX:NVCN's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 21.7
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Neovasc's Cash Flow from Operations per share for the three months ended in Dec. 2022 was C$-2.66. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2022 was C$-11.92.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 53.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 78.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 47.40% per year.

During the past 13 years, Neovasc's highest 3-Year average Operating Cash Flow per Share Growth Rate was 90.20% per year. The lowest was -125.50% per year. And the median was 11.40% per year.

Neovasc Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Neovasc's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neovasc Price-to-Operating-Cash-Flow Chart

Neovasc Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Neovasc Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Neovasc's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Neovasc's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neovasc's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neovasc's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Neovasc's Price-to-Operating-Cash-Flow falls into.

Neovasc Price-to-Operating-Cash-Flow Calculation

Neovasc's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	40.15	/	-11.916
	=

Neovasc's Share Price of today is C$40.15.
Neovasc's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-11.92.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Neovasc Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Neovasc's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Neovasc (TSX:NVCN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neovasc Inc (TSX:NVCN) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

13562 Maycrest Way, Suite 5138, Richmond, BC, CAN, V6V 2J7

Website

https://www.neovasc.com

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.